Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias
FranceLong-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat
FranceStudy on Baricitinib for Patients with Relapsing or Naïve Dermatomyositis
FranceStudy on Ruxolitinib for Treating Inclusion Body Myositis in Patients
FranceStudy on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1
FranceStudy on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1
FranceStudy on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)
FranceStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
FranceStudy on the Safety and Effects of Cipaglucosidase Alfa and Miglustat for Children with Infantile-onset Pompe Disease
FranceEfficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
FranceStudy on the Safety and Effects of SQY51 for Children and Adults with Duchenne Muscular Dystrophy
FranceStudy of Microdystrophin (GNT0004) Gene Therapy for Duchenne Muscular Dystrophy in Boys Who Can Walk
Francepowered by
